Archives

by in
Entry Author Date Location
Vertex, N-of-One, Flexion & More Boston Life Sciences News 06/01/12 Boston
Vertex Shares Drop on Mistake in Cystic Fibrosis Drug Data 05/29/12 Boston
Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers 05/21/12 National
Boston Life Sciences News From Vertex, Eleven, RXi, & More 05/11/12 Boston
Vertex Shares Boom on Cystic Fibrosis Results 05/07/12 Boston
Investing in Biotech Isn’t Just for Investors Anymore 04/09/12 National
Late Add: John Mendlein Joins “Reinventing Biotech” Lineup April 3 03/29/12 Seattle
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks 03/26/12 National
Enanta, Satori, Vertex & More of the Week’s Life Sciences Newsmakers 02/24/12 Boston
Vertex Stays in HepC Game, as All-Oral Combo Passes Small Study 02/23/12 Boston
Enanta Enters HepC Big Leagues, With $34M Upfront From Novartis 02/21/12 Boston
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News 02/03/12 Boston
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says 02/01/12 Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug 01/31/12 Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers 01/27/12 Boston
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More 01/26/12 San Diego
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
The Top 10 Traffic-Getting Stories at Xconomy San Diego 12/28/11 San Diego
San Diego Life Sciences Roundup: BeneChill, Sotera, Imthera, & More 12/16/11 San Diego
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition 12/15/11 Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News 11/11/11 Boston
Vertex Stock Drops 17% Over Two Days, As Potent Hep C Rivals Emerge 11/08/11 Boston
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News 10/28/11 Boston
Vertex Flips Into the Black for First Time, as Hepatitis C Drug Beats Expectations Again 10/27/11 Boston
This Week’s Xconomy Report on WGBH: Security Innovation, Vertex, West Coast Acquisitions, & More 10/21/11 Boston
Third Rock Launches Sage, Glaxo Malaria Vaccine Relies on Agenus Technology, Vertex Seeks Approval of Cystic Fibrosis Drug, & More Boston-Area Life Sciences News 10/21/11 Boston
Page 2 of 9 « previous page · next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Zillions of Biotech Conferences Want You. Which Should You Attend?
  4. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  5. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.